Anders N. Pedersen

3.1k total citations
39 papers, 2.2k citations indexed

About

Anders N. Pedersen is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anders N. Pedersen has authored 39 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 13 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anders N. Pedersen's work include Breast Cancer Treatment Studies (13 papers), Advanced Radiotherapy Techniques (11 papers) and Galectins and Cancer Biology (9 papers). Anders N. Pedersen is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Advanced Radiotherapy Techniques (11 papers) and Galectins and Cancer Biology (9 papers). Anders N. Pedersen collaborates with scholars based in Denmark, Sweden and United Kingdom. Anders N. Pedersen's co-authors include Lena Specht, Stine Korreman, Håkan Nyström, Trine Jakobi Nøttrup, Martin Berg, Birgitte Vrou Offersen, Lasse Rye Aarup, Ingelise Jensen, Nils Brünner and S.J. Zimmermann and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Anders N. Pedersen

38 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders N. Pedersen Denmark 23 1.2k 981 698 619 435 39 2.2k
Birgitte Vrou Offersen Denmark 32 2.3k 2.0× 1.0k 1.0× 684 1.0× 901 1.5× 986 2.3× 125 3.3k
Kyle C. Cuneo United States 29 432 0.4× 346 0.4× 648 0.9× 571 0.9× 666 1.5× 111 2.4k
Gregory S. Sibley United States 19 604 0.5× 976 1.0× 1.5k 2.1× 999 1.6× 460 1.1× 41 2.6k
Cornelius J. McGinn United States 27 453 0.4× 761 0.8× 1.5k 2.1× 550 0.9× 1.6k 3.6× 38 3.3k
Kathy Han Canada 22 343 0.3× 363 0.4× 459 0.7× 651 1.1× 865 2.0× 102 2.7k
Ritsuko Komaki United States 32 512 0.4× 749 0.8× 2.4k 3.4× 830 1.3× 1.2k 2.7× 71 3.7k
Shulian Wang China 30 470 0.4× 921 0.9× 1.4k 1.9× 1.0k 1.6× 1.4k 3.1× 177 3.5k
Thierry Gil Belgium 22 453 0.4× 239 0.2× 2.1k 3.0× 339 0.5× 1.1k 2.6× 94 3.5k
Jeffrey Meyer United States 23 227 0.2× 713 0.7× 790 1.1× 557 0.9× 621 1.4× 125 2.3k
Melanie C. Smitt United States 20 897 0.8× 171 0.2× 532 0.8× 784 1.3× 1.4k 3.2× 45 2.4k

Countries citing papers authored by Anders N. Pedersen

Since Specialization
Citations

This map shows the geographic impact of Anders N. Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders N. Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders N. Pedersen more than expected).

Fields of papers citing papers by Anders N. Pedersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders N. Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders N. Pedersen. The network helps show where Anders N. Pedersen may publish in the future.

Co-authorship network of co-authors of Anders N. Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of Anders N. Pedersen. A scholar is included among the top collaborators of Anders N. Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders N. Pedersen. Anders N. Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
MacKinnon, Alison C., Duncan C. Humphries, James A. Roper, et al.. (2024). Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liver. European Journal of Pharmacology. 985. 177077–177077. 4 indexed citations
2.
Nielsen, Mette Holck, Lars Stenbygaard, Anders N. Pedersen, et al.. (2024). Benefit of respiratory gating in the Danish Breast Cancer Group partial breast irradiation trial. Radiotherapy and Oncology. 194. 110195–110195. 3 indexed citations
3.
Kim, Henry, Emmanuel Klein, James A. Roper, et al.. (2023). Evaluating the affinity and kinetics of small molecule glycomimetics for human and mouse galectin-3 using surface plasmon resonance. SLAS DISCOVERY. 28(5). 233–239. 8 indexed citations
4.
Aslanis, Vassilios, Robert J. Slack, Alison C. MacKinnon, et al.. (2023). Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants. Cancer Chemotherapy and Pharmacology. 91(3). 267–280. 25 indexed citations
5.
Thomsen, Mette S., Jan Alsner, Hanne Melgaard Nielsen, et al.. (2022). Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast Cancer Group phase III randomized Partial Breast Irradiation trial. Radiotherapy and Oncology. 177. 231–235. 21 indexed citations
6.
Offersen, Birgitte Vrou, Jan Alsner, Hanne Melgaard Nielsen, et al.. (2022). Partial Breast Irradiation Versus Whole Breast Irradiation for Early Breast Cancer Patients in a Randomized Phase III Trial: The Danish Breast Cancer Group Partial Breast Irradiation Trial. Journal of Clinical Oncology. 40(36). 4189–4197. 44 indexed citations
7.
Humphries, Duncan C., Ross Mills, Brian J. McHugh, et al.. (2022). Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activation. Frontiers in Pharmacology. 13. 949264–949264. 22 indexed citations
8.
Vuong, Lynda, Claire Rooney, Brian J. McHugh, et al.. (2019). An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade. Cancer Research. 79(7). 1480–1492. 104 indexed citations
9.
Rasmussen, Thomas, Andreas Kjær, Martin Lyngby Lassen, et al.. (2019). No changes in myocardial perfusion following radiation therapy of left-sided breast cancer: A positron emission tomography study. Journal of Nuclear Cardiology. 28(5). 1923–1932. 7 indexed citations
10.
Nielsen, Mette Holck, Martin Berg, Anders N. Pedersen, et al.. (2013). Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncologica. 52(4). 703–710. 146 indexed citations
11.
Pedersen, Anders N., Susanne Möller, Karina Dahl Steffensen, et al.. (2010). Supraclavicular recurrence after early breast cancer: a curable condition?. Breast Cancer Research and Treatment. 125(3). 815–822. 32 indexed citations
12.
Persson, Gitte Fredberg, et al.. (2008). Can audio coached 4D CT emulate free breathing during the treatment course?. Acta Oncologica. 47(7). 1397–1405. 21 indexed citations
13.
Korreman, Stine, Trine Juhler‐Nøttrup, Gitte Fredberg Persson, et al.. (2008). The role of image guidance in respiratory gated radiotherapy. Acta Oncologica. 47(7). 1390–1396. 37 indexed citations
14.
Korreman, Stine, et al.. (2007). Intra- and interfraction breathing variations during curative radiotherapy for lung cancer. Radiotherapy and Oncology. 84(1). 40–48. 82 indexed citations
15.
Korreman, Stine, Anders N. Pedersen, Lasse Rye Aarup, et al.. (2006). Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer. International Journal of Radiation Oncology*Biology*Physics. 65(5). 1375–1380. 132 indexed citations
16.
Korreman, Stine, Anders N. Pedersen, Mirjana Josipović, et al.. (2006). Cardiac and pulmonary complication probabilities for breast cancer patients after routine end-inspiration gated radiotherapy. Radiotherapy and Oncology. 80(2). 257–262. 60 indexed citations
17.
Pedersen, Anders N., Stine Korreman, Håkan Nyström, & Lena Specht. (2004). Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold. Radiotherapy and Oncology. 72(1). 53–60. 207 indexed citations
18.
Schrohl, Anne‐Sofie, Ib Jarle Christensen, Anders N. Pedersen, et al.. (2003). Tumor Tissue Concentrations of the Proteinase Inhibitors Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and Plasminogen Activator Inhibitor Type 1 (PAI-1) Are Complementary in Determining Prognosis in Primary Breast Cancer. Molecular & Cellular Proteomics. 2(3). 164–172. 62 indexed citations
19.
Høyer‐Hansen, Gunilla, Maria J. A. G. Hamers, Anders N. Pedersen, et al.. (2000). Loss of ELISA specificity due to biotinylation of monoclonal antibodies. Journal of Immunological Methods. 235(1-2). 91–99. 35 indexed citations
20.
Mynster, Tommie, et al.. (1997). Effect of Heating on Extracellular Bioactive Substances in Stored Human Blood. PubMed. 43(5). 799–803. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026